Conmed Corp.
NYSE:CNMD 3:51:36 PM EDT
| Market Cap (Intraday) | 2.00B |
| Current PE | 20.29 |
| Forward PE | 16.26 |
| 2yr Forward PE | 13.22 |
| 10-Day MA | $65.48 |
| 50-Day MA | $70.01 |
| 200-Day MA | $76.49 |
Conmed Corp. Stock, NYSE:CNMD
11311 Concept Boulevard, Largo, Florida 33773
United States of America
Phone: +1.727.392.6464
Number of Employees: 4000
Description
CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. Its products include AirSeal and insufflation, allograft cartilage and tissue, arthroplasty, biliary and endoscopic ultrasound, biomedical sensors and electrodes, biopsy and polypectomy, dilators and accessories, electrosurgical units, fixation devices, hemostasis, implants and suture anchors, infection prevention, patient positioning, and related products. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.